Cost data for individual patients included in clinical studies: No amount of statistical analysis can compensate for inadequate costing methods

Health Economics

Volumn 11, Issue 8, 2002, Pages 735-739

  Graves, Nicholas ^a   Walker, Damian ^a   Raine, Rosalind ^a   Hutchings, Andrew ^a   Roberts, Jennifer A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CBA; CEA; Clinical evaluation; CUA

Indexed keywords

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; METHODOLOGY; PATIENT; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

COST-BENEFIT ANALYSIS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HEALTH SERVICES RESEARCH; HUMANS; PATIENT CARE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 0036913613     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.683     Document Type: Article

References (10)

1. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: a review of published studies. BMJ 1998; 317: 1195-1200.
2. Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Ser Policy Res 1998; 3(4): 233-245.
3. Jefferson T, Smith R, Yee Y, Drummond M, Pratt M, Gale R. Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet. JAMA 1998; 280(3): 275-277.
4. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275-283.
5. Gravelle H, Rees R. Microeconomics (4th edn). Longman: London, 1992.
6. Gold MR, Siegel JE, Russell LN, Weinstein MC. Cost-Effectiveness in Health Care and Medicine. Oxford University Press: Oxford, 1996.
7. Sassi F, McKee M, Roberts JA. Economic evaluation of diagnostic technology: methodological challenges and viable solutions. Int J Technol Assessment Health Care 1995; 13(4): 613-630.
8. Menon D, Schubert F, Torrance GW. Canada's new guidelines for the economic evaluation of pharmaceuticals. Med Care 1996; 34(12): DS77-DS86.
9. Bryan A, Beech R. Cost information in a provider market for health care: a note. Financial Accountability Management 1991; 7(2): 99-105.
10. Finkler SA. The distinction between costs and charges. Ann Int Med 1982; 96: 102-109.